Amyris (NASDAQ:AMRS) Releases Earnings Results, Beats Estimates By $0.02 EPS

Share on StockTwits

Amyris (NASDAQ:AMRS) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.51) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.53) by $0.02, Fidelity Earnings reports. The business had revenue of $34.95 million during the quarter, compared to the consensus estimate of $21.60 million.

Shares of Amyris stock traded up $0.54 during trading hours on Friday, reaching $4.52. The company’s stock had a trading volume of 2,224,200 shares, compared to its average volume of 1,905,229. The company’s 50 day simple moving average is $4.00 and its 200 day simple moving average is $3.88. The stock has a market cap of $431.70 million, a P/E ratio of -1.79 and a beta of 0.91. Amyris has a one year low of $1.87 and a one year high of $7.26.

A number of research analysts have recently issued reports on AMRS shares. BidaskClub upgraded shares of Amyris from a “sell” rating to a “hold” rating in a research report on Wednesday. HC Wainwright restated a “buy” rating and issued a $11.00 price target on shares of Amyris in a research report on Friday, October 11th.

About Amyris

Amyris, Inc, an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products.

Further Reading: What economic reports are most valuable to investors?

Earnings History for Amyris (NASDAQ:AMRS)

Receive News & Ratings for Amyris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.